Explorer les evidences

96,3 %96.3% of participants were comfortable with fingerprint technology for patient identification in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublié 2021Journal of medical Internet researchPubMeddocument de 11 observations

43,2 %Among the 37 newly diagnosed participants, 16 (43.2%) were late retesters.

KenyaVIH/sidapublié 2022BMC public healthPubMeddocument de 9 observations

1,6 aORPatients aged >64 years were more likely to have SARS-CoV-2 infection compared to those aged 12–24 years, with an adjusted odds ratio of 1.60.

KenyaCOVID-19observé July 2022 to October 2023publié 2026VaccinePubMeddocument de 8 observations

1,91 adjusted_risk_ratioDrug resistance penalty score (DR-PS) ≥ 30 was associated with poor adherence to antiretroviral therapy (adjusted risk ratio = 1.91).

KenyaVIH/sidaobservé 2019 to 2023publié 2025VirusesPubMeddocument de 8 observations

0,24 per_1000A one percent increase in population within 2 hours of a VLBW hospital was associated with a reduction of neonatal mortality rate by 0.24.

Kenyamortalité néonatalepublié 2022PLOS global public healtheurope_pmcdocument de 7 observations

0,24 per_100_person-yearsSix HIV infections were observed over 2531 person-years of observation, corresponding to an incidence of 0.24 cases per 100 person-years.

KenyaVIH/sidapublié 2021The Lancet. Global healthPubMeddocument de 9 observations

2,76 relative_risk_ratioInfectious mosquitoes were nearly 3 times more likely than non-infectious mosquitoes to bite Plasmodium falciparum-infected individuals, with a relative risk ratio of 2.76 (95% CI: 1.65–4.61).

Kenyapaludismeobservé 15-month cohort in western Kenyapublié 2024Nature communicationsPubMeddocument de 7 observations

In urban areas, all Anopheles funestus sensu lato samples were Anopheles funestus sensu stricto in Kisumu city, Kenya.

Kenyapaludismepublié 2025Malaria journalPubMeddocument de 26 observations

50,9 %The prevalence of high-risk human papillomavirus (HR-HPV) among women living with HIV (WLWH) was 50.9% from January 2015 to March 2020.

Kenyahigh-risk human papillomavirusobservé January 2015 to March 2020publié 2023AIDS (London, England)PubMeddocument de 9 observations

43,2 %Among 28,134 febrile patients encountered for malaria diagnostic testing in the health facilities, 12,143 (43.2%) were positive.

Kenyapaludismepublié 2020PloS oneeurope_pmcdocument de 3 observationsDOI 10.1371/journal.pone.0240058

2,14 aPRPregnancy was significantly associated with a higher prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya, with an adjusted prevalence ratio of 2.14.

KenyaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations

8,64 yearsThe hypertensive group had a significantly longer HIV duration of 8.64 ± 4.63 years compared to 6.86 ± 4.04 years in the non-hypertensive group.

KenyaVIH/sidaobservé 2020publié 2022The Pan African medical journalPubMeddocument de 7 observations

51,6 %Women in the Targeted arm were more likely to be at high risk for HIV acquisition at baseline (51.6% vs. 33.3%).

KenyaVIH/sidapublié 2023Journal of the International AIDS SocietyPubMeddocument de 9 observations

4 treatment_instancesOf 9 biopsies performed for suspected Kaposi sarcoma in Kenya and Uganda, 4 received Kaposi sarcoma-specific treatment.

Kenya · Ougandasarcome de Kaposipublié 2026AIDS (London, England)PubMeddocument de 4 observations

1,29 odds_ratioThe ITN campaign did not reduce malaria incidence in the population as a whole (odds ratio [OR] after ITN distribution versus before, 1.29, 95% CI: 1.00–1.66, p = 0.049).

Kenyapaludismeobservé 2011–2013publié 2020The American journal of tropical medicine and hygienePubMeddocument de 3 observations

Widowhood has been associated with greater HIV morbidity and mortality.

KenyaVIH/sidapublié 2023Social science & medicine (1982)europe_pmcdocument de 5 observationsDOI 10.1016/j.socscimed.2023.116031

29,3 %Availability of NCD medicines was 29.3% in private for-profit drug outlets for medicines on the Standard Treatment Guidelines.

Kenyamaladies non transmissiblesobservé 2016publié 2020BMJ openPubMeddocument de 4 observations

18,27 %HIV prevalence among people who inject drugs (PWIDs) in the Coastal region was 18.27% (adjusted).

KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 17 observations

26,5 °CWith a time lag of 15 weeks in Ukunda, the relationship between malaria cases and temperature peaks at 26–27 °C.

Kenyapaludismepublié 2025Malaria journalPubMeddocument de 8 observations

11 %Of the women who received an RDT in the ISTp-DP arm, 11% (32/289) tested positive for malaria.

Kenyapaludismepublié 2020Malaria journalPubMeddocument de 6 observations

400 individualsA total of 400 adults without symptoms of malaria residing in Western Kenya were screened for the presence of P. falciparum gametocytes.

Kenyapaludismepublié 2025Malaria journalPubMeddocument de 6 observations

1,25 biting_rate_ratioBiting rates were higher on Plasmodium falciparum-infected individuals, with a biting rate ratio of 1.25 (95% CI: 1.01–1.55).

Kenyapaludismeobservé 15-month cohort in western Kenyapublié 2024Nature communicationsPubMeddocument de 7 observations

33,33 %One third of women had perinatal moderate-to-severe depressive symptoms.

Kenyaperinatal moderate-to-severe depressive symptomspublié 2022The lancet. PsychiatryPubMeddocument de 9 observations

92,7 %The negative predictive value of routine malaria microscopy was 92.7%.

Kenyapaludismepublié 2006Tropical medicine & international health : TM & IHeurope_pmcdocument de 15 observations

25 US$/DALYCompared with monthly doses of sulfadoxine-pyrimethamine, monthly doses of dihydroartemisinin-piperaquine resulted in an incremental cost-effectiveness ratio of $25 per DALY averted.

Kenyapaludismepublié 2020The Lancet. Global healthPubMeddocument de 6 observations